The pros and cons of living on the edge.

Suppr

超能文献

作者信息

Butman Samuel

出版信息

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):504. doi: 10.1002/ccd.21351.

DOI:10.1002/ccd.21351

PMID:17896412

Abstract

摘要

相似文献

The pros and cons of living on the edge.

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):504. doi: 10.1002/ccd.21351.

Late vascular response at the edges of sirolimus analogous-eluting stents in diabetic patients: An intravascular ultrasound study.

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):498-503. doi: 10.1002/ccd.21139.

Gender medicine and drug eluting coronary stents.

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):814-6. doi: 10.1002/ccd.22850.

Treating the left main bifurcation lesion: the "three stent solution".

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):42-3. doi: 10.1002/ccd.21906.

Stent strut fracture: seeing is believing.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):619-20. doi: 10.1002/ccd.21569.

Direct stenting in the DES era: Can we do better?

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):513-4. doi: 10.1002/ccd.21348.

Optimal stent expansion and complete neointimal coverage: does this association make sense?

JACC Cardiovasc Interv. 2009 Oct;2(10):995-6. doi: 10.1016/j.jcin.2009.08.003.

A generation 2.5 drug-eluting stent?

JACC Cardiovasc Interv. 2009 Oct;2(10):986-8. doi: 10.1016/j.jcin.2009.06.017.

Stent fracture: an unusual cause of late restenosis after sirolimus-eluting stent placement.

Catheter Cardiovasc Interv. 2007 Jun 1;69(7):988-91. doi: 10.1002/ccd.21027.

Acute stent recoil from aggressive post-dilation of a second-generation drug-eluting stent.

JACC Cardiovasc Interv. 2013 Mar;6(3):311-3. doi: 10.1016/j.jcin.2012.08.027.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The pros and cons of living on the edge.

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):504. doi: 10.1002/ccd.21351.

Late vascular response at the edges of sirolimus analogous-eluting stents in diabetic patients: An intravascular ultrasound study.

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):498-503. doi: 10.1002/ccd.21139.

Gender medicine and drug eluting coronary stents.

Catheter Cardiovasc Interv. 2010 Nov 15;76(6):814-6. doi: 10.1002/ccd.22850.

Treating the left main bifurcation lesion: the "three stent solution".

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):42-3. doi: 10.1002/ccd.21906.

Stent strut fracture: seeing is believing.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):619-20. doi: 10.1002/ccd.21569.

Direct stenting in the DES era: Can we do better?

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):513-4. doi: 10.1002/ccd.21348.

Optimal stent expansion and complete neointimal coverage: does this association make sense?

JACC Cardiovasc Interv. 2009 Oct;2(10):995-6. doi: 10.1016/j.jcin.2009.08.003.

A generation 2.5 drug-eluting stent?

JACC Cardiovasc Interv. 2009 Oct;2(10):986-8. doi: 10.1016/j.jcin.2009.06.017.

Stent fracture: an unusual cause of late restenosis after sirolimus-eluting stent placement.

Catheter Cardiovasc Interv. 2007 Jun 1;69(7):988-91. doi: 10.1002/ccd.21027.

Acute stent recoil from aggressive post-dilation of a second-generation drug-eluting stent.

JACC Cardiovasc Interv. 2013 Mar;6(3):311-3. doi: 10.1016/j.jcin.2012.08.027.